Teva Pharmaceutical Industries raised its 2024 revenue and earnings guidance after beating third-quarter profit forecasts, ...

Finnish insurer Sampo beat third-quarter earnings expectations on Wednesday, citing higher underwriting profit, strong ...

The medical device maker reported big growth in revenue and earnings, driven by strong product sales and a recent major ...

El Pollo Loco's traffic is down due to limited menu innovation and higher prices, even as it maintains positive comparable ...

Shares of Credit Agricole SA fell nearly 6% on Wednesday after the French bank reported mixed quarterly results, marked by an ...

(Reuters) -German software developer TeamViewer raised its outlook for adjusted core profit margin for the full year after ...

Learn about the latest developments at troubled insurance company AIG as workers arrive at the offices, signaling potential ...

Profits at P.A.M. Transport slumped 61% in the third quarter of 2024 on the back of continued truckload market weakness and ...

Buoyant appetite for data center power generators underpinned a 23.3% year-on-year jump in Cummins Inc.’s profit in the third quarter, trumping weak demand for heavy-duty truck engines.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.06 per share. The natural gas and electricity ...

Q3 2024 Earnings Call Nov 05, 2024, 5:00 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

NEW YORK (AP) — NEW YORK (AP) — Royalty Pharma (RPRX) on Wednesday reported third-quarter net income of $544 million. On a per-share basis, the New York-based company said it had profit of 92 cents.